Insys Therapeutics, Inc. (INSY) Cut to "Strong Sell" at Zacks Investment Rese...
According to Zacks, "Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care.
Start the conversation, or Read more at AmericanBankingNews.com.